Imexpharm aims for quality and affordability


A panorama picture of Imexpharm’s factory in Binh Duong province that met EU-GMP standards - Viet Nam News/ANN

Hanoi: “Vietnam is one of the fast-growing pharmaceutical markets in the world,” says Tran Thi Dao, general director of Imexpharm, adding that “after the Covid-19 pandemic, the country’s pharmaceutical industry still maintains growth momentum even though some other industries show signs of slowing down”.

According to a recent report by the Drug Administration of Vietnam, the total value of Vietnam’s pharmaceutical market was estimated to increase from about US$2.7bil in 2015 to US$7bil in 2022.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Vietnam , pharmaceutical

Next In Business News

Petron says storm-hit jetty could affect financial performance
Tomei FY25 net profit jumps to RM106.82mil, revenue hits RM1.31bil
UUE Holdings unit bags two contracts in Singapore worth RM68mil
TechStore wins RM55mil government job
CelcomDigi appoints Albern Murty CEO
Ringgit climbs to 3.92 vs US dollar ahead of Malaysia's GDP data
EHB announces proposed business diversification
PJBumi gets RM4.3mil BIM consultant work
Boustead Holdings offers RM0.48 per share to privatise BHIC
Teo Seng remains cautiously optimistic on growth as poultry demand holds

Others Also Read